Analysis of 2373 stage III gastric cancer patients who underwent curative gastrectomy revealed that a higher count of negative lymph nodes (NLN) (>14) significantly improved the 5-year overall survival rate compared to patients with a lower count (43.7% vs 23.1%). This study establishes NLN count as an independent prognostic factor for stage III gastric cancer patients and supports its inclusion in clinical practice for predicting patient outcomes.
Journal Article by Liu L, Ren J (…) Lei X et 4 al. in Am Surg